Geneva, Feb. 13 -- International Clinical Trials Registry received information related to the study (ChiCTR2600118216) titled 'Clinical Study on Cervical Cancer: Spatial Segmentation Brachytherapy-Induced Immunotherapy Combined with Radical Concurrent Chemoradiotherapy' on Feb. 3.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: Linfen Central Hospital
Condition:
Cervical cancer
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2025-12-30
Target Sample Size: Trial group:15;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=301726
Published by HT Digital Content Services with permission from Health Daily Digest....